Polymorphisms in CYP1A1, CYP1A2, CYP2C8, CYP2E1, CYP2J2, and CYP3A4 are generally less predictive, but data show that predictive variants exist [14]
Proper dosing, consistent administration, and adequate duration all determine success
is a founder, science advisory board member (SAB) and equity holder in Syros, C4, Allorion, Lighthorse, Voronoi, Inception, Matchpoint, Versant, Redtree, Shenandoah (board member), Larkspur (board member) and Soltego (board member)
Mechanism of Action Stimulates angiogenesis (formation of new blood vessels) Increases fibroblast activity and collagen synthesis Reduces pro-inflammatory cytokines and promotes anti-inflammatory cascades Enhances tendon-to-bone healing , muscle fiber regeneration, and gut lining repair Works through interaction with the nitric oxide system , aiding circulation and tissue oxygenation BPC157 promotes tendon and ligament healing, accelerates wound closure, and stabilizes vascular response after injury. Sikiric et al., Current Pharmaceutical Design Applications Joint pain, tendonitis, ligament tears Ulcers, IBS, leaky gut Muscle strain, post-surgical recovery Neural repair and recovery from nerve compression Post-cycle inflammation and tissue stress Delivery Administered via subcutaneous injection , near site of injury or systemically Can also be taken orally for GI-related issues (due to gastric stability) BPC157 Overview and How It Works BPC157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice
